Arcus Biosciences Inc
NYSE:RCUS
| Market Cap (Intraday) | 1.33B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $15.88 |
| 50-Day MA | $17.49 |
| 200-Day MA | $17.68 |
Arcus Biosciences Inc Stock, NYSE:RCUS
3928 Point Eden Way, Hayward, California 94545
United States of America
Phone: +1.510.694.6200
Number of Employees: 577
Description
Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.